You are here: Home » News-CM » Companies » Results
Business Standard

Shukra Pharmaceuticals reports standalone net profit of Rs 0.42 crore in the December 2019 quarter

Capital Market 

Sales rise 240.35% to Rs 3.88 crore

Net profit of Shukra Pharmaceuticals reported to Rs 0.42 crore in the quarter ended December 2019. There were no net profit/loss reported during the previous quarter ended December 2018. Sales rose 240.35% to Rs 3.88 crore in the quarter ended December 2019 as against Rs 1.14 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales3.881.14 240 OPM %24.4819.30 -PBDT0.950.22 332 PBT0.600.04 1400 NP0.420 0

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, February 15 2020. 11:21 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU